| CTX310 CRISPR Therapeutics AG 2443415 17 Apr 2024 | Registered: Registered/protected | Cells for medical or clinical use in the field of in vivo gene editing... Class 005 Class 005 Pharmaceutical Products Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy in class 5 Class 042 Class 042 Computer & Software Services & Scientific Services Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy in class 42 | |
